Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines-Reference-Cited by-同舟云学术

Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines

Published:2023-05 Issue:22 Volume:41 Page:3422-3428
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Pillsbury Alexis,Phillips Anastasia,Deng Lucy^ORCID,Quinn Helen,Macartney Kristine^ORCID,Gidding Heather^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference53 articles.

1. Australian Government Department of Health. Approved COVID-19 vaccines 2022 [March 24, 2022]. Available from: https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/approved-vaccines.

2. Australian Government Department of Health and Aged Care. Vaxzevria (AstraZeneca) vaccine and thrombosis with thrombocytopenia (TTS) 2023 [Available from: https://www.health.gov.au/our-work/covid-19-vaccines/advice-for-providers/clinical-guidance/tts.

3. Australian Government Department of Health Therapeutic Goods Administration. COVID-19 vaccine weekly safety report - 09-03-2023 2022 [Available from: https://www.tga.gov.au/news/covid-19-vaccine-safety-reports.

4. Australian Government Department of Health. COVID-19 vaccine rollout update - 03 August 2022 2022 [Available from: https://www.health.gov.au/sites/default/files/documents/2022/08/covid-19-vaccine-rollout-update-3-august-2022.pdf.

5. World Health Organization. Adverse Events Following Immunization (AEFI) [March 24, 2022]. Available from: https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/health-professionals-info/aefi.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What would have happened anyway? Population data source considerations when estimating background incident rates of adverse events following immunisation to inform vaccine safety;Vaccine;2024-02

2. Incidence and Nature of Short-Term Adverse Events following COVID-19 Second Boosters: Insights from Taiwan’s Universal Vaccination Strategy;Vaccines;2024-01-31

3. Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis;Vaccine;2023-10